{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:33:34Z","timestamp":1783661614700,"version":"3.55.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Transl. Res."],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12265-025-10638-7","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T09:53:55Z","timestamp":1750154035000},"page":"888-899","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of CACNA1C-Positive Patients Evaluated in a Tertiary Genetic Heart Rhythm Clinic"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1410-2449","authenticated-orcid":false,"given":"Liwei","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn M.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Tester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayank","family":"Sardana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Giudicessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"10638_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.pediatrneurol.2022.10.013","volume":"138","author":"RJ Levy","year":"2023","unstructured":"Levy RJ, Timothy KW, Underwood JFG, Hall J, Bernstein JA, Pasca SP. A Cross-Sectional Study of the Neuropsychiatric Phenotype of CACNA1C-Related Disorder. Pediatr Neurol. 2023;138:101\u20136.","journal-title":"Pediatr Neurol"},{"key":"10638_CR2","doi-asserted-by":"publisher","first-page":"1021009","DOI":"10.3389\/fcvm.2022.1021009","volume":"9","author":"J Borbas","year":"2022","unstructured":"Borbas J, Vamos M, Hategan L, Hanak L, Farkas N, Szakacs Z, Csupor D, Tel B, Kupo P, Csanyi B, Nagy V, Komocsi A, Habon T, Hegyi P, Sepp R. Geno- and phenotypic characteristics and clinical outcomes of CACNA1C gene mutation associated Timothy syndrome, \u201ccardiac only\u201d Timothy syndrome and isolated long QT syndrome 8: A systematic review. Front Cardiovasc Med. 2022;9:1021009.","journal-title":"Front Cardiovasc Med"},{"key":"10638_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cell.2004.09.011","volume":"119","author":"I Splawski","year":"2004","unstructured":"Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R, Napolitano C, Schwartz PJ, Joseph RM, Condouris K, Tager-Flusberg H, Priori SG, Sanguinetti MC, Keating MT. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell. 2004;119:19\u201331.","journal-title":"Cell"},{"key":"10638_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.668546","volume":"9","author":"R Bauer","year":"2021","unstructured":"Bauer R, Timothy KW, Golden A. Update on the Molecular Genetics of Timothy Syndrome. Front Pediatr. 2021;9: 668546.","journal-title":"Front Pediatr"},{"key":"10638_CR5","doi-asserted-by":"crossref","unstructured":"Splawski I, Timothy KW, Decher N, Kumar P, Sachse FB, Beggs AH, Sanguinetti MC, Keating MT (2005) Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci U S A 102: 8089\u20138096; discussion 8086\u20138088","DOI":"10.1073\/pnas.0502506102"},{"key":"10638_CR6","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.hrcr.2023.05.012","volume":"9","author":"NR Einhorn","year":"2023","unstructured":"Einhorn NR, Patel RS, Bennett JL, McDonald TV. Hypertrophic cardiomyopathy and long QT syndrome in cardiac-only Timothy syndrome. HeartRhythm Case Rep. 2023;9:560\u20134.","journal-title":"HeartRhythm Case Rep"},{"key":"10638_CR7","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/CIRCEP.115.002745","volume":"8","author":"NJ Boczek","year":"2015","unstructured":"Boczek NJ, Ye D, Jin F, Tester DJ, Huseby A, Bos JM, Johnson AJ, Kanter R, Ackerman MJ. Identification and Functional Characterization of a Novel CACNA1C-Mediated Cardiac Disorder Characterized by Prolonged QT Intervals With Hypertrophic Cardiomyopathy, Congenital Heart Defects, and Sudden Cardiac Death. Circ Arrhythm Electrophysiol. 2015;8:1122\u201332.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10638_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.hrthm.2018.08.030","volume":"16","author":"D Ye","year":"2019","unstructured":"Ye D, Tester DJ, Zhou W, Papagiannis J, Ackerman MJ. A pore-localizing CACNA1C-E1115K missense mutation, identified in a patient with idiopathic QT prolongation, bradycardia, and autism spectrum disorder, converts the L-type calcium channel into a hybrid nonselective monovalent cation channel. Heart Rhythm. 2019;16:270\u20138.","journal-title":"Heart Rhythm"},{"key":"10638_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/ajmg.a.36924","volume":"167A","author":"A Hiippala","year":"2015","unstructured":"Hiippala A, Tallila J, Myllykangas S, Koskenvuo JW, Alastalo TP. Expanding the phenotype of Timothy syndrome type 2: an adolescent with ventricular fibrillation but normal development. Am J Med Genet A. 2015;167A:629\u201334.","journal-title":"Am J Med Genet A"},{"key":"10638_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jacep.2017.08.007","volume":"4","author":"KA Dufendach","year":"2018","unstructured":"Dufendach KA, Timothy K, Ackerman MJ, Blevins B, Pflaumer A, Etheridge S, Perry J, Blom NA, Temple J, Chowdhury D, Skinner JR, Johnsrude C, Bratincsak A, Bos JM, Shah M. Clinical Outcomes and Modes of Death in Timothy Syndrome: A Multicenter International Study of a Rare Disorder. JACC Clin Electrophysiol. 2018;4:459\u201366.","journal-title":"JACC Clin Electrophysiol"},{"key":"10638_CR11","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1161\/CIRCULATIONAHA.107.701243","volume":"117","author":"I Goldenberg","year":"2008","unstructured":"Goldenberg I, Moss AJ, Peterson DR, McNitt S, Zareba W, Andrews ML, Robinson JL, Locati EH, Ackerman MJ, Benhorin J, Kaufman ES, Napolitano C, Priori SG, Qi M, Schwartz PJ, Towbin JA, Vincent GM, Zhang L. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation. 2008;117:2184\u201391.","journal-title":"Circulation"},{"key":"10638_CR12","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.hrthm.2011.05.018","volume":"8","author":"JM Horner","year":"2011","unstructured":"Horner JM, Horner MM, Ackerman MJ. The diagnostic utility of recovery phase QTc during treadmill exercise stress testing in the evaluation of long QT syndrome. Heart Rhythm. 2011;8:1698\u2013704.","journal-title":"Heart Rhythm"},{"key":"10638_CR13","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1016\/j.jacc.2020.10.024","volume":"76","author":"A Sugrue","year":"2020","unstructured":"Sugrue A, van Zyl M, Enger N, Mancl K, Eidem BW, Oh JK, Bos JM, Asirvatham SJ, Ackerman MJ. Echocardiography-Guided Risk Stratification for Long QT Syndrome. J Am Coll Cardiol. 2020;76:2834\u201343.","journal-title":"J Am Coll Cardiol"},{"key":"10638_CR14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1253\/circj.CJ-19-1101","volume":"84","author":"M Fukuyama","year":"2020","unstructured":"Fukuyama M, Ohno S, Ozawa J, Kato K, Makiyama T, Nakagawa Y, Horie M. High Prevalence of Late-Appearing T-Wave in Patients With Long QT Syndrome Type 8. Circ J. 2020;84:559\u201368.","journal-title":"Circ J"},{"key":"10638_CR15","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.hrthm.2020.02.017","volume":"17","author":"CJ MacIntyre","year":"2020","unstructured":"MacIntyre CJ, Rohatgi RK, Sugrue AM, Bos JM, Ackerman MJ. Intentional nontherapy in long QT syndrome. Heart Rhythm. 2020;17:1147\u201350.","journal-title":"Heart Rhythm"},{"key":"10638_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.120.008830","volume":"13","author":"T Niaz","year":"2020","unstructured":"Niaz T, Bos JM, Sorensen KB, Moir C, Ackerman MJ. Left Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome. Circ Arrhythm Electrophysiol. 2020;13: e008830.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10638_CR17","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jacc.2021.04.026","volume":"78","author":"KE Tobert","year":"2021","unstructured":"Tobert KE, Bos JM, Garmany R, Ackerman MJ. Return-to-Play for Athletes With Long QT Syndrome or Genetic Heart Diseases Predisposing to Sudden Death. J Am Coll Cardiol. 2021;78:594\u2013604.","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-025-10638-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-025-10638-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-025-10638-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T14:02:47Z","timestamp":1757944967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-025-10638-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10638"],"URL":"https:\/\/doi.org\/10.1007\/s12265-025-10638-7","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles outlined in the Declaration of Helsinki. Informed consent was obtained from all patients for being included in the study. Participants also provided explicit consent for the publication of study findings, ensuring that their identities remain confidential. No identifying information will be disclosed in any publications resulting from this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Dr. Ackerman is a consultant for Abbott, Boston Scientific, Bristol Myers Squibb, Illumina, Invitae, Medtronic, Tenaya Therapeutics, and UpToDate. MJA and Mayo Clinic have license agreements with AliveCor, Anumana, ARMGO Pharma, Prolaio, Solid Biosciences, and Thryv Therapeutics. Dr. Giudicessi is a consultant for Avidity Biosciences and serves as a principal investigator for clinical trials supported by Tenaya Therapeutics. However, none of these entities were involved in this study. Other authors declare no conflicts.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}